Ipsen To File Cabozantinib For Liver Cancer In 1H 2018

 
• By Lucie Ellis-Taitt
  
Cirrhosis
Ipsen to file cabozantinib for liver cancer in Europe after Positive Phase III
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas